Blog
39 Articles
![Dr. Elizabeth Jaffee](https://letswinpc.org/wp-content/uploads/2022/10/Elizabeth-Jaffee.jpg)
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
![Dr. Gulam Manji](https://letswinpc.org/wp-content/uploads/2024/02/Gulam-Manji.jpg)
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
![Dr. Vinod Balachandran](https://letswinpc.org/wp-content/uploads/2022/10/Balachandran.jpg)
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
![Slide of pancreatic cancer](https://letswinpc.org/wp-content/uploads/2023/08/Adenocarcinoma_of_Pancreas_FNA.jpg)
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
![neon lights in the shape of DNA](https://letswinpc.org/wp-content/uploads/2023/06/neon-DNA.jpg)
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
![altered photo of bottles in teal and aqua](https://letswinpc.org/wp-content/uploads/2023/05/snap-cap-bottles.jpg)
Chemo and SBRT for Inoperable Pancreatic Cancer
For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.
![black and white photo of DNA reading](https://letswinpc.org/wp-content/uploads/2022/09/ct2022mar11.jpg)
Testing an Approved Drug for a Specific Mutation
Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.
![microscope image of zebrafish scales in blues and greens](https://letswinpc.org/wp-content/uploads/2022/09/ct2020sep22.jpg)
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
![Chemistry tubes with purple, yellow and white liquids in a red rack](https://letswinpc.org/wp-content/uploads/2022/09/ct2020jul31.jpg)
Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer
This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.
![red tops and black tops of new beakers against a silver background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020jun11.jpg)
Chemotherapy Plus Minimally Invasive Surgery for Pancreatic Cancer
Researchers want to know if irreversible electroporation (IRE) makes it easier for chemotherapy to reach pancreatic cancer cells.